Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

MRK · Merck & Company, Inc.

$144.71 -1.91% Sep 10 close
Detected setup Trend Only · Setup Score 86/100

Stand aside — setup invalidated

Setup score 86, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about MRK

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$MRK

Merck & Company, Inc.

Merck & Company, Inc. is a mega-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $357B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 1
$144.71 latest close
Verdict · setup score 86/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 86, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

MRK-1.91%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. -1.31 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.91% From the open-2.29% Range position16% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $144.71 -1.9% Sep 10 close
52W High $156.92 7.8% below high
Wks Since High 2w
Base Depth 7.5% 8.2% today
RS Rank 78 percentile of scan
SMA 50 $135.67
Avg Vol 9,650,681
Rel Vol (Sep 10) 0.78×
More stats
52W Low $77.58
Tight Wks 0
Base B1
SMA 200 $119.18
RS Line vs High -6.5%
RS Line Slope +9.6% ▲
Group Rank #27/58
ADR% 2.4%
ATR(14) $3.79 (2.6%)
Vol Pace (live) N/A
U/D Vol 1.42
A/D Days 19A / 14D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 85thpercentile of the 52-week range
$77.58low
$156.92high

MRK Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for MRK.

Create Free Account

Technical Analysis Report Card

$MRK · $144.71 · as of 2026-09-10 · multi-factor read
80
/ 100
Technicals 80/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$135.67 ↑
100-day$125.99 ↑
200-day$119.18 ↑
Bullish (50 > 200)

RSI (14)

Reading51.7 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-1.140

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width40% · 17.6%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.42 · Neutral
Rel volume0.78×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $156.9252-week high
Price · $144.71now
S · $126.22swing level
S · $120.16swing level
S · $116.50swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$145.35
38.2%$138.19
50.0%$132.41
61.8%$126.63
78.6%$118.39

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for MRK — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 83 (leader)
Want this read in a legend's voice? Ask a Legend about MRK
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 7/10 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $144.71, MA150 $123.70, MA200 $119.18
1.2 150-day MA > 200-day MAMA150 $123.70 vs MA200 $119.18
Failing evidence
2. Quarterly EPS growth ≥ 25%From SEPA scan
2. ROE ≥ 17%From SEPA scan
7/10 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 83
N: Near 52-week high or RS line new high7.8% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%Data unavailable
A: Annual earnings & revenue qualityRev +1.3%
3/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $144.71 vs MA200 $119.18
Failing evidence
Volume expansion above averageVolume ratio 0.78x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$144.71
Relative strengthRS 83
Failing evidence
Volume vs average0.78x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$144.71
Relative strengthRS 83
Failing evidence
Volume vs average0.78x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$144.71
Relative strengthRS 83
Failing evidence
Volume vs average0.78x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
148RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -3 A+
A: 11 D: 14 Net: -365 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +1%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 83
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -7.8%

Method Playbook

Trade it like Minervini EXACT LEVELS · PRO
Minervini C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

86 setup score
RS Score 83
Trend template 8/8
Why This Setup?
Trend Only · schematic

Gatekeeper 8/8 | Strong trend (8/8) | Top RS (83) | Accumulation (1.6× up/dn vol) | Stage 2

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • A relative-strength leader — partly met RS rank 78 — middling
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.8× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $144.71 vs SMA150 $123.70 / SMA200 $119.18
SMA 150 above SMA 200 SMA150 $123.70 vs SMA200 $119.18
SMA 200 trending up Slope +5.84 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $135.67
Price above SMA 50 $144.71 vs SMA50 $135.67
30%+ above 52-week low +86.5% from $77.58
Within 25% of 52-week high -7.8% from $156.92
RS score above 70 RS 83

Fundamentals

52W Range
85%
Mkt Cap SEC
357.0B
Rev YoY
+1%
EPS TTM
$7.28
P/E TTM
19.9x
Float
2.5B

Company

Company profile
Merck & Company, Inc.
MRK · NYSE · Health Technology · Pharmaceuticals: Major

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$107.90
W. Resist
$156.92
Weekly Structure

Scan History

20× streak
Sep 09: 50 (Wyckoff SOS)Sep 10: 50 (Wyckoff SOS)Sep 11: 50 (Wyckoff SOS)Sep 11: 83 (Trend Only)Sep 11: 85 (Trend Only)Sep 11: 86 (Trend Only)86
Sep 11
Trend Only ✓ Gate
86
Sep 11
Trend Only ✓ Gate
85
Sep 11
Trend Only ✓ Gate
83
Sep 11
Wyckoff SOS ✓ Gate
50
Sep 10
Wyckoff SOS ✓ Gate
50 0.0%
Sep 09
Wyckoff SOS ✓ Gate
50 -1.9%

Get the full picture on MRK

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial